GAO says FDA is too lax on DTC ads policing

Share this article:
The Government Accountability Office ripped the FDA for lax policing of DTC advertising, saying the agency was slow to act on dubious drug ads due to inconsistent standards and bureaucratic snafus. “We believe that regulatory letters should be issued more quickly,” said the GAO's report.

Share this article:

Email Newsletters

More in News

BI rethinks hepatitis business, posts 2013 results

BI rethinks hepatitis business, posts 2013 results

Boehringer Ingelheim says it is no longer pursuing an interferon-free combination of faldaprevir and deleobuvir.

Roche wraps quarter with two fewer pipeline medications

Roche wraps quarter with two fewer pipeline medications

Roche also announced first-quarter sales shrank 1%.

2013 favored specialists, specialty Rx

2013 favored specialists, specialty Rx

The latest IMS Institute for Healthcare Informatics assessment of 2013's prescription drug use shows that 2.3% of prescriptions account for 30% of a patient's out-of-pocket prescription costs.